Skip to main content
星昊医药 logo

星昊医药 — Investor Relations & Filings

Ticker · 920017 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 417 across all filing types
Latest filing 2025-04-22 Audit Report / Informat…
Country CN China
Listing Beijing Stock Exchange 920017

About 星昊医药

https://www.sunho.com.cn/

Beijing Sunho Pharmaceutical Co., Ltd. is a technology-driven enterprise specializing in the research, development, manufacturing, and commercialization of advanced pharmaceutical preparations. The company focuses on high-barrier drug delivery systems, including sustained-release, controlled-release, and complex injection technologies. Its core business encompasses the production of a diverse portfolio of chemical drugs and biological products, alongside comprehensive Contract Development and Manufacturing Organization (CDMO) services. Sunho Pharmaceutical operates modern, GMP-compliant production facilities designed to support the entire lifecycle of drug development, from pilot-scale testing to large-scale commercial manufacturing. By leveraging its proprietary formulation platforms, the company provides integrated solutions for complex dosage forms, catering to both domestic and international pharmaceutical markets.

Recent filings

Filing Released Lang Actions
北京星昊医药股份有限公司控股股东及其他关联方资金占用情况的专项说明
Audit Report / Information Classification · 95% confidence The document is titled as a "专项说明" (special explanation) regarding the use of funds by controlling shareholders and related parties for Beijing Xinghao Pharmaceutical Co., Ltd. It references an audit report issued by Beijing Dehao International Certified Public Accountants for the fiscal year ending December 31, 2024, and mentions compliance with Chinese securities regulatory requirements related to disclosure of non-operating fund occupation and related party transactions. The document includes a summary table of non-operating fund occupation and related party fund transactions for 2024. It is a standalone audit-related explanatory statement focusing on a specific issue (fund occupation by controlling shareholders and related parties), not a full annual report or financial statement. It is not a mere announcement or certification but a detailed audit-related special explanation. This fits the category of Audit Report / Information (AR), which covers standalone audit reports and related disclosures excluding full annual reports. The document length (6265 characters) supports it being a substantive report rather than a brief announcement. FY 2024
2025-04-22 Chinese
关于补选第六届董事会审计委员会委员和提名委员会委员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of new members to the company's board committees, specifically the audit committee and nomination committee. It details changes in board composition and committee membership, including the resignation of a previous independent director and the appointment of a new one. There is no financial data, report publication, or regulatory certification involved. The content clearly relates to board/management information about changes in the company's board and committees. Therefore, the appropriate classification is Board/Management Information (MANG). The document length and content confirm it is not a report or announcement of a report but a governance-related announcement.
2025-04-10 Chinese
国浩律师（上海）事务所关于北京星昊医药股份有限公司2025年第二次临时股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, attendance, and voting procedures of the 2025 second extraordinary general meeting of shareholders of Beijing Xinghao Pharmaceutical Co., Ltd. It details the legality and validity of the meeting's procedures and voting results. The document does not contain financial statements, earnings data, or management discussion but focuses on the legal compliance and validation of the shareholder meeting and its resolutions. This type of document is typically classified as Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports on the official voting results and procedural compliance of a shareholder meeting.
2025-04-10 Chinese
2025年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the company's 2025 second extraordinary general meeting of shareholders. It includes details about the meeting date, attendance, voting results, and changes in board members. The content focuses on the meeting proceedings and official voting outcomes rather than presenting financial data or detailed reports. The document length is short (1731 characters) and it is clearly a resolution announcement from a shareholders meeting, not a full report or presentation. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-04-10 Chinese
第六届董事会第三十九次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 39th meeting of the 6th Board of Directors of Beijing Xinghao Pharmaceutical Co., Ltd. It details the meeting date, attendance, agenda items, and voting results, specifically about the election of a new independent director and committee member. There is no financial data, no mention of annual or quarterly reports, no audit information, no earnings data, and no regulatory filings beyond the board meeting resolution. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-04-10 Chinese
董事辞职公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company director, including details about the director's resignation date, reasons, and impact on the company. It does not contain financial data, audit information, or any report content. It specifically relates to changes in the company's board of directors. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on management change, confirming this classification.
2025-04-10 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.